It still very early but this is the second study released by the Mayo Clinic in regards to the use of convalescent plasma in COVID19 treatments.
https://www.medrxiv.org/content/10.1101/2020.08.12.20169359v1
It still needs peer review and ALOT more data collection and analysis. Hopefully this continues to be a trend of good news in the treatment. Early intervention and transfusion seems to be key along with other treatment protocols to help mitigate the sick from getting too far gone.
https://www.medrxiv.org/content/10.1101/2020.08.12.20169359v1
Quote:
Relevance: The relationships between reduced mortality and both earlier time to transfusion and higher antibody levels provide signatures of efficacy for convalescent plasma in the treatment of hospitalized COVID-19 patients. This information may be informative for the treatment of COVID-19 and design of randomized clinical trials involving convalescent plasma.
It still needs peer review and ALOT more data collection and analysis. Hopefully this continues to be a trend of good news in the treatment. Early intervention and transfusion seems to be key along with other treatment protocols to help mitigate the sick from getting too far gone.